Get started
Work

A Phase 2 Trial of Colesevelam for Lenalidomide-Associated Diarrhea

Year: 2022
Type: article
Study design: Clinical Trial
Source: Blood
DOI: 10.1182/blood-2022-164851
Authors: Malin Hultcrantz, Hani Hassoun, Neha Korde, Sham Mailankody, Tala Shekarkhand, Miranda Burge, Kylee H Maclachlan, Dhwani Patel, Urvi A Shah, David J. Chung, Michael Scordo, Kelly Barnett, Jenna Blaslov, Meghan Salcedo, Julia Caple, Linh Tran, Selena Hamid, Oscar B Lahoud, Heather Landau, Gunjan L. Shah, Sergio A Giralt, Andriy Derkach, Carlyn Tan, Cody Peer, William D. Figg, Saad Usmani, Ola Landgren, Alexander M Lesokhin
Institutions: Memorial Sloan Kettering Cancer Center, National Institutes of Health, National Cancer Institute, Center for Cancer Research, University of Miami, Sylvester Comprehensive Cancer Center
Language: English
Subfield: Hematology
Field: Medicine
Open Access status: closed
OpenAlex ID: W4310127211
FWCI:
Cites:
Cited by:
Related to: 10